Australia vs Singapore: Cases started on MDR-TB treatment
Australia
25
in 2024
Singapore
22
in 2024
Australia rank
102nd
Singapore rank
104th
Cases started on MDR-TB treatment over time
- Australia
- Singapore
How they compare
Australia currently reports 25 against 22 in Singapore, a difference of 3.
That makes Australia's figure about 1.1 times Singapore's.
The two have swapped places 4 times across 17 shared years of data; in 2008 it was Australia ahead.
Australia ranks 102nd and Singapore ranks 104th of 193 countries.
Australia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Australia | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 22.5 | 3.5 | 19 | Australia |
| 2010s | 26.8 | 13.6 | 13.2 | Australia |
| 2020s | 55.2 | 19.4 | 35.8 | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Australia or Singapore?
- Australia, at 25 against 22 in Singapore as of 2024.
- What is the difference in cases started on mdr-tb treatment between Australia and Singapore?
- 3, with Australia ahead.
- How many years of comparable data are there for Australia and Singapore?
- 17 years are reported by both, from 2008 to 2024.
- How do Australia and Singapore rank globally for cases started on mdr-tb treatment?
- Australia ranks 102nd and Singapore ranks 104th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.